CA9 and urinary bladder cancer: In a variety of solid tumors, including CRC,19, 20 bladder cancer,27 non‐small cell lung cancer,28 triple‐negative breast cancer,29 and pancreatic cancer,30 CA9 has been widely confirmed as an oncogenic factor and diagnostic molecular marker.